Figure 6.
Immunohistochemistry staining of JeKo-1 tumors extracted from mice in Figures 4, 5 against various biomarkers. The tumors were harvested from control, 1 and 5 mg/kg (i.p. weekly) M69-MMAE treatment groups from experiment four and Bortezomib and M69-MMAE combination (Bortezomib (0.75 mg/kg, i.p. weekly and M69-MMAE, 5mg/kg i.p. twice weekly) from experiment five. Ki67 staining showing proliferation of JeKo-1; and Cleaved caspase-3 showing the apoptotic cell death. The tonsil tissue was used as a positive control for various IHC staining.